|
Volumn 29, Issue 7, 2002, Pages 1211-1221
|
Late phase II study of exemestane in postmenopausal patients with breast cancer resistant to anti-estrogenic agents
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANDROSTANE DERIVATIVE;
ANTIESTROGEN;
ANTINEOPLASTIC AGENT;
AROMATASE INHIBITOR;
ENZYME INHIBITOR;
ESTROGEN;
EXEMESTANE;
ADULT;
AGED;
ARTICLE;
BLOOD;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG RESISTANCE;
FEMALE;
HOT FLUSH;
HUMAN;
HYPERTENSION;
MIDDLE AGED;
MULTICENTER STUDY;
PHASE 2 CLINICAL TRIAL;
POSTMENOPAUSE;
REPRODUCIBILITY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANDROSTADIENES;
ANTINEOPLASTIC AGENTS;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
ENZYME INHIBITORS;
ESTROGEN ANTAGONISTS;
ESTROGENS;
FEMALE;
HOT FLASHES;
HUMANS;
HYPERTENSION;
MIDDLE AGED;
POSTMENOPAUSE;
REPRODUCIBILITY OF RESULTS;
|
EID: 0036634604
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|